CA
NZ
UK
AU
IND
US
Dermata Therapeutics, Inc. is preparing to bring its first direct‑to‑consumer skincare solution to market in late August 2026. The upcoming offering is positioned as a core element of the company’s entry into the consumer‑focused skincare arena. This transition from traditional pharmaceutical pipelines to a …
EnGene Therapeutics Inc. recently shed light on the non-muscle invasive bladder cancer (NMIBC) market through a key opinion leader (KOL) event held on August 11, 2026. This virtual session focused on emerging insights regarding market dynamics and growth opportunities for investigational therapies in this …
Bausch & Lomb (NYSE: BLCO) named Thomas J. Appio chairman and added four new directors on August 10, 2026, reshaping its board after a series of resignations. The company also appointed Dr. Laurence Paul as lead independent director, further adjusting its governance framework.
Cardinal Health (NYSE: CAH) announced a strong fourth-quarter fiscal year 2026 performance, reporting aDiluted Earnings per Share(EPS) of $2.91, which surpassed the consensus estimate of $2.44. This marks a notable increase as the healthcare distributor capitalized on effective operational strategies and growingDemandacross its segments. …
Avalyn Pharma Inc. (NASDAQ: AVLN) has positioned itself for future growth by securing $316.6 million from its recent initial public offering, extending its financial runway into 2029. This capital infusion translates to approximately 21% of Avalyn's current marketCapitalizationof $1.5 billion, providing substantial resources for …
AVITA Medical has entered a Global Amendment with Stedical Scientific, enhancing its revenue-sharing model for PermeaDerm products. This change allows AVITA to increase its share to 80% on glove-form products, compared to previous arrangements. In addition, significant growth opportunities arise with expanded rights to …
Arbutus Biopharma Corporation (NASDAQ: ABUS) reported a net loss of $5.1 million for the second quarter ended June 30, contrasting sharply with the $2.5 million profit from the same quarter last year. The company also revealed totalRevenueof $1.0 million this quarter, significantly down from …
AstraZeneca PLC (LSE: AZN) reported strong second-quarter earnings, highlighting total revenue of $15.38 billion, a 5% increase from the previous year. This performance reflects solid execution in key segments, particularly oncology, where revenue saw a notable 16% rise to $7.33 billion. The company's coreEarningsper …
AirSculpt Technologies (NASDAQ: AIRS) announced on August 5 that it will move its corporate headquarters from the Miami Beach address at 1111 Lincoln Road, Suite 802, FL 33139 to a new location at 2023 West Platt Street, Tampa, FL 33605.
Annexon, Inc. (NASDAQ: ANNX) announced today that it has secured a $200 million credit facility, significantly boosting its financial position and extending its operational runway into 2028. ThisCapitalinfusion arrives at a time when the company is making key advancements in its drug pipelines targeting …
Please wait processing your request...